Author

Steven M. Fischer

Agilent Technologies (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:metabolomics· 2 Approach:statistical model· 2

Frequent Co-Authors

Benjamin I. Schwartz· 2 shared Csaba KonràdiD· 2 shared Davinder K. Sandhu· 2 shared Dipa Roychoudhury· 2 shared Elizabeth L. Calder· 2 shared Giovanni ManfrediiD· 2 shared Hibiki KawamataiD· 2 shared Kirsten G. BredvikiD· 2 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Benjamin I. Schwartz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Accelerated trans-sulfuration metabolically defines a discrete subclass of ALS patients

Qiuying Chen, Davinder K. Sandhu, Csaba Konràd, Dipa Roychoudhury, Benjamin I. Schwartz, Roger R. Cheng, Kirsten G. Bredvik, Hibiki Kawamata, Elizabeth L. Calder, Lorenz Studer, Steven M. Fischer, Giovanni Manfredi, Steven S. Gross

The paper identifies a subclass of sporadic ALS patients with metabolic defects in trans-sulfuration, characterized by increased cysteine and glutathione synthesis and distinct metabolic responses.

bioRxiv · Apr 16, 2019 · PreprintNeuroscience

Identification of a Distinct Metabolomic Subtype of Sporadic ALS Patients

The paper identifies a distinct metabolomic subtype in sporadic ALS patients through metabolite profiling and multi-omics integration, showing increased cysteine metabolism and potential therapeutic targets.

bioRxiv · Sep 13, 2018 · PreprintNeuroscience